cyberknife Melanoma
<  Back    I Melanoma Home I    Next >
Bibliography
  1. Wanebo HJ, Fortner JG, Woodruff J, MacLean B, Binkowski E. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg. 1975 Sep;182(3):302-15.

  2. Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg. 1975 Nov;182(5):572-5.

  3. Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D. Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study. Ann Surg Oncol. 2006 Apr 12; [Epub ahead of print]

  4. Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg. 2005 Jul;201(1):37-47.

  5. Bridger AG, Smee D, Baldwin MA, Kwok B, Bridger GP. Experience with mucosal melanoma of the nose and paranasal sinuses. ANZ J Surg. 2005 Apr;75(4):192-7

  6. Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP. Head and neck mucosal melanoma. Am J Clin Oncol. 2005 Dec;28(6):626-30.

  7. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21(1):43-52.

  8. de Wilt JH, Farmer SE, Scolyer RA, McCaughan BC, Thompson JF. Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Res. 2005 Dec;15(6):531-7

  9. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004 Apr 1;22(7):1293-300.

  10. Geara FB, Ang KK. Radiation therapy for malignant melanoma. Surg Clin North Am. 1996 Dec;76(6):1383-98

  11. Ballo MT, Garden AS, Myers JN, Lee JE, Diaz EM Jr, Sturgis EM, Morrison WH, Gershenwald JE, Ross MI, Weber RS, Ang KK. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005 Aug;27(8):718-21

  12. Bonnen MD, Ballo MT, Myers JN, Garden AS, Diaz EM Jr, Gershenwald JE, Morrison WH, Lee JE, Oswald MJ, Ross MI, Ang KK. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. 2004 Jan 15;100(2):383-9.

  13. Ballo MT, Ang KK. Radiation therapy for malignant melanoma. Surg Clin North Am. 2003 Apr;83(2):323-42.

  14. Habermalz HJ, Fischer JJ. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer. 1976 Dec;38(6):2258-62.

  15. Doss LL, Memula N. The radioresponsiveness of melanoma. Int J Radiat Oncol Biol Phys. 1982 Jul;8(7):1131-4.

  16. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, JanJan N, Lipsett J. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):429-32

  17. Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD. Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer. 2005 Dec 15;104(12):2784-91

  18. Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106.

  19. Herfarth KK, Izwekowa O, Thilmann C, Pirzkall A, Delorme S, Hofmann U, Schadendorf D, Zierhut D, Wannenmacher M, Debus J. Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther Onkol. 2003 Jun;179(6):366-71.

  20. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):898-903

  21. Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg. 2005;83(5-6):213-21.

  22. Muller K, Nowak PJ, de Pan C, Marijnissen JP, Paridaens DA, Levendag P, Luyten GP. Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):116-22

  23. Emara K, Weisbrod DJ, Sahgal A, McGowan H, Jaywant S, Michaels H, Payne D, Pintilie M, Laperriere NJ, Simpson ER. Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: preliminary results. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):94-100.

  24. Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escude L, Caro M, Potter R, Goitein G, Lomax AJ, Miralbell R. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):373-84.




<  Back    I Melanoma Home I    Next >


Written by Donald B. Fuller, M.D. – Radiation Oncologist       



            Central San Diego
           
5395 Ruffin Road, Suite 103
           San Diego, CA 92123 
           (858) 505-4100 
           (800) 470-1256
          North County San Diego
       477 N. El Camino Real, Suite D-101
       Encinitas, CA. 92024
       (760) 230-6706
       (800) 470-1256
Cyberknife Centers of San Diego   I  Physician Home       
Patient & Family Home  I   Notice of Privacy Practices        

2008 © All Rights Reserved